Study guide
16.4 NAACCR EDITS, Over-ride Flags & Data Validation
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
16.4 NAACCR EDITS, Over-ride Flags & Data Validation
Key Takeaways Explain This Topic AI
NAACCR distributes edits in metafiles organized into edit sets for each purpose, such as the CoC hospital set "Hosp: CoC Required - All" and the sets used for central registry, NPCR and SEER submissions.
Single-item edits check that a code is valid, inter-field edits check combinations within one tumor record, and inter-record edits check consistency across a patient's tumor records.
When an edit fails, check the source record first: correct the abstract if it is wrong, and set an over-ride flag only when a rare but valid combination is confirmed and documented in text.
Over-ride flags include Age/Site/Histology [1990], Sequence Number/Diagnostic Confirmation [2000], Site/Histology/Laterality/Sequence [2010], Surgery/Diagnostic Confirmation [2020], Site/Type [2030], Histology/Behavior [2040] and Leukemia or Lymphoma/Diagnostic Confirmation [2070].
Passing edits shows only that codes are valid and consistent; visual editing, re-abstracting audits and casefinding audits (Section 6.3) are still needed to measure accuracy.
Last updated: September 2026
What EDITS are
EDITS are computerized logic checks, maintained through NAACCR, that registry software runs on each abstract and on data files. Their parts:
Part Description
Metafile The distributed file containing every edit, lookup table and edit set for a NAACCR version. It is updated with each new data standard.
Edit set A named group of edits for a purpose. Examples: the CoC hospital set, central registry sets, and the NPCR and SEER submission sets.
Edit A single rule, for example "Primary Site, Morphology-Type ICDO3 (SEER IF25)".
Lookup tables Tables of valid codes and combinations, such as the site/histology validation list.
Types of edits:
Single-item (field) edits: the value is valid for the item. For example, Laterality must be 0–5 or 9, and dates must be valid.
Inter-field edits: combinations within one tumor record. Examples: primary site with histology, site with laterality, diagnostic confirmation with histology, surgery with diagnostic confirmation, age with site and histology, and AJCC or Summary Stage with schema.
Inter-record edits: consistency across all records for one patient . Examples: the same date of birth and vital status on every tumor, and a coherent set of sequence numbers.
How CoC programs use edits
Date Case Completed–CoC [2092] is set by the software when the items required for the case's Class of Case are abstracted and the case passes the "Hosp: CoC Required - All" edit set (Section 13.1).
The NCDB runs edits on RCRS submissions and rejects or flags records that fail. Programs correct them and resubmit.
Standard 6.1 quality control covers casefinding, abstracting timeliness, unknown values and accuracy reviews. Edits help, but they do not replace the 10% accuracy review.
Resolving an edit error
Read the message. Note which items the edit compares.
Look up the edit's logic. The edit description explains what combination is flagged and why.
Check the source documents (pathology, operative report, imaging, physician notes) and the coding manuals.
If the abstract is wrong , correct it. This is the usual outcome. Typical causes are a transposed code, a laterality entered for an unpaired site, or a sequence number not updated after a new primary.
If the combination is rare but correct , document the evidence in text and set the matching over-ride flag to 1. The flag tells the edit that the combination was reviewed. It is not a way to clear an error queue.
Re-run edits.
Over-ride flags and review items (NAACCR item numbers)
Item NAACCR # Used when
Age/Site/Histology Interfield Review 1990 An unusual age for the site or histology is confirmed (for example, a childhood tumor type in an adult)
Sequence Number/Diagnostic Confirmation 2000 Multiple primaries where one is not microscopically confirmed
Site/Histology/Laterality/Sequence Interrecord Review 2010 Paired-site tumors of the same histology that are confirmed as separate primaries
Surgery/Diagnostic Confirmation 2020 Surgery of the primary site was done but the case is not microscopically confirmed (or the reverse)
Site/Type Interfield Review 2030 An unusual site and histology combination not on the validation list is confirmed. The CoC version of the edit accepts Override CoC-Site/Type or Override Site/Type as equivalent
- Histology/Behavior 2040 A histology with an unusual behavior is confirmed
- Type of Reporting Source/Sequence Number 2050 DCO or autopsy-only cases with a sequence number conflict
- Sequence Number/Ill-Defined Site 2060 An ill-defined or unknown primary site among multiple primaries
- Leukemia or Lymphoma/Diagnostic Confirmation 2070 Leukemia or lymphoma that is not microscopically confirmed
Site/Behavior; Site/EOD/Diagnosis Date; Site/Laterality/EOD; Site/Laterality/Morphology 2071–2074 Specific site-related edits
Name/Sex Assigned at Birth 2078 A name that looks inconsistent with Sex Assigned at Birth is verified
Override Site/TNM-Stage Group 1989 An AJCC-stageable pediatric site staged by another system and coded 88 for AJCC
Examples:
For the CoC version of the site/type edit, skin C44 with histologies 8000–8110 (keratinocyte carcinomas) needs no override.
Male breast cancer is a valid combination and does not fail a site/sex edit. Sex-impossible combinations, such as a male patient with a primary site of cervix, point to a coding error.
Sex Assigned at Birth (2026)
The SEER 2026 manual introduces Sex Assigned at Birth [225] , effective for 2026 diagnoses and replacing the old Sex item, with codes 1 male, 2 female, 9 not stated or unknown . If sex is unknown, assign 1 for male genital sites (C600–C639) and 2 for female genital sites (C510–C589). Code 9 is used for DSD with sex not clearly defined, or when only a non-binary or transgender identity is documented without sex at birth. Edits compare this item with sex-specific primary sites.
Dates in edits
Dates are transmitted as CCYYMMDD , with blanks for unknown trailing parts and date flag items explaining why a date is blank. The old "99" unknown convention belonged to the pre-2010 format. Edits check that dates are valid and in logical order. For example, the date of diagnosis cannot follow the date of last contact, and the date of first course of treatment is not usually before the date of diagnosis.
What edits cannot do
Edits cannot tell whether a valid code is the right code. For example, C504 versus C502 with the same histology passes every edit, even if the tumor was in the upper-inner quadrant. Accuracy needs:
- visual editing (a second person reviewing text against codes);
- the Standard 6.1 accuracy review (10% of analytic cases, up to 200);
- central registry re-abstracting and casefinding audits ;
NAACCR certification criteria, including 100% passing EDITS for Gold (Section 6.3).
Worked examples
Edit: "Laterality, Primary Site" fails for C18.7 coded laterality 1. The sigmoid colon is not a paired site, so correct laterality to 0 . No override.
Edit: Site/Type fails for primary melanoma of the esophagus, confirmed by IHC (S100, SOX10) and a physician statement with no skin primary. Document the evidence in text and set Site/Type Interfield Review [2030] = 1.
Edit: inter-record, Vital Status 0 on one record and 1 on another for the same patient. Vital status is patient-level, so correct both records to 0 and use the same date of last contact.